The estimated Net Worth of John Frederick Ek is at least $8.06 Milion dollars as of 21 January 2021. Mr. Ek owns over 50,449 units of GenMark Diagnostics Inc stock worth over $5,498,741 and over the last 6 years he sold GNMK stock worth over $1,435,845. In addition, he makes $1,129,380 as Chief Financial Officer at GenMark Diagnostics Inc.
Johnny has made over 24 trades of the GenMark Diagnostics Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he exercised 50,449 units of GNMK stock worth $1,212,794 on 21 January 2021.
The largest trade he's ever made was exercising 50,449 units of GenMark Diagnostics Inc stock on 21 January 2021 worth over $1,212,794. On average, Johnny trades about 5,900 units every 24 days since 2019. As of 21 January 2021 he still owns at least 228,733 units of GenMark Diagnostics Inc stock.
You can see the complete history of Mr. Ek stock trades at the bottom of the page.
Johnny Ek serves as Chief Financial Officer of the Company. Prior to serving as the Company’s Chief Financial Officer, Mr. Ek served as the Company’s Vice President, Finance and Accounting and Corporate Controller from November 2013 to February 2019. Prior to joining the Company, Mr. Ek served as Vice President and International Controller for Affymetrix, Inc., a leading provider of cellular and genetic analysis products, from May 2013 to November 2013. Prior to joining Affymetrix, Mr. Ek served as Controller of eBioscience, Inc., a privately held provider of flow cytometry and immunoassay reagents, from October 2010 through eBioscience’s acquisition by Affymetrix in May 2013. Prior to joining eBioscience, Mr. Ek held various roles with Ernst & Young LLP from May 2001 to October 2010, most recently serving as Senior Manager. Mr. Ek is a Certified Public Accountant (CPA) and earned a B.S. in finance from Brigham Young University and a Masters degree in accountancy (MAcc) from the University of Notre Dame’s Mendoza College of Business.
As the Chief Financial Officer of GenMark Diagnostics Inc, the total compensation of Johnny Ek at GenMark Diagnostics Inc is $1,129,380. There are 1 executives at GenMark Diagnostics Inc getting paid more, with Scott Mendel having the highest compensation of $1,749,300.
Johnny Ek is 43, he's been the Chief Financial Officer of GenMark Diagnostics Inc since 2019. There are 9 older and no younger executives at GenMark Diagnostics Inc. The oldest executive at GenMark Diagnostics Inc is Daryl Faulkner, 71, who is the Independent Director.
Over the last 14 years, insiders at GenMark Diagnostics Inc have traded over $27,572,889 worth of GenMark Diagnostics Inc stock and bought 454,838 units worth $2,182,328 . The most active insiders traders include Hany Massarany, Jon Faiz Kayyem a Kevin C Oboyle. On average, GenMark Diagnostics Inc executives and independent directors trade stock every 5 days with the average trade being worth of $141,403. The most recent stock trade was executed by Michael Gleeson on 14 April 2021, trading 27,667 units of GNMK stock currently worth $326,471.
GenMark Diagnostics Inc executives and other stock owners filed with the SEC include: